| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.088 | 0.06 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.054 | 0.3 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.056 | 0.3 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.052 | 0.3 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.051 | 0.3 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.049 | 0.4 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.038 | 0.4 |